30 Years Of Research Leads To NeuroFlex

After 30 years of research into eye and head movement analysis, ‘NeuroFlex’, a testing device for more than 200 neurological disorders, will be used in clinics, hospitals, and the sidelines of sports fields.
Share on facebook
Share on google
Share on twitter
Share on linkedin

Saccade Analytics, partners of Digital Health Organization, are working to translate the advanced research into accessible tools, allowing more people the opportunity to access the future standard of patient care.

Saccade co-founder, Isabel Galiana, discussed NeuroFlex in an interview with RBC Royal Bank.

“NeuroFlex evaluates brain function based on eye and head movements in a quick seven-minute test in virtual reality (VR),” Galiana said.

“More specifically, what NeuroFlex does is provide diagnostic metrics to health care professionals to evaluate the extent of a deficiency and to provide direction for personalized rehabilitation.

“Essentially what Mimi (Saccade co-founder, Dr. Mimi Galiana) had developed was a method to accurately and quickly analyse eye and head movements and provide metrics that can be used to evaluate concussions, vestibular disorders and, in fact, over 200 neurological disorders that present in eye and head movements…

“We would love to get NeuroFlex in the hands of GPs, and we hope that everyone will have the opportunity to have their brain function evaluated on a regular basis,” she said.

Digital Health Organization managing director, Nathan Thynne, said NeuroFlex will help from the grassroots level, helping identify and help plan preventative treatments for concussions, vestibular conditions, and neurological conditions.

“We’re very focused on brain health and with NeuroFlex, we can start to look at things regarding concussions, vestibular conditions and neurological conditions,” Thynne said.

“Once we start to understand an individual’s brain health, then we can bring in individual health as a whole.

“What we’re doing, we’ve got a very big focus on the grassroots community, and by having a plan where we can roll out NeuroFlex and start to test on children and adolescents, we can then also roll out into the general community and get NeuroFlex into the hands of GPs.

“By using NeuroFlex to identify brain health, and hence, strengths or weaknesses, we will save a tremendous amount of money not only for individuals, but for the healthcare system through prevention in the medium to long term.”

According to the World Health Organization, Half of all mental illnesses begin by the age of 14 and three-quarters by mid-20s. 

If untreated, these conditions severely influence children’s development, their educational attainments, and their potential to live fulfilling and productive lives. 

“If you can identify it at an earlier age, we can use personalised programs based off strengths and weaknesses to increase performance and create brain resilience,” Thynne said. 

“Then individuals can have a better potential to handle mental health illnesses.

“The earlier prevention strategies are introduced, the better long-term development an individual can have, leading to a better quality of life,” he said.

John Doe

John Doe

Click edit button to change this text. Lorem ipsum dolor sit amet consectetur adipiscing elit dolor

Leave a reply

Scroll to Top